ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 215 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,065,000 | +34.5% | 26,354 | +91.6% | 0.01% | +20.0% |
| Q2 2015 | $792,000 | +181.9% | 13,757 | +211.3% | 0.01% | +150.0% |
| Q1 2015 | $281,000 | -61.6% | 4,419 | -62.7% | 0.00% | -50.0% |
| Q4 2014 | $731,000 | -75.2% | 11,837 | -84.4% | 0.00% | -76.5% |
| Q3 2014 | $2,943,000 | +257.2% | 75,802 | +297.3% | 0.02% | +325.0% |
| Q1 2014 | $824,000 | +642.3% | 19,077 | +585.0% | 0.00% | – |
| Q4 2013 | $111,000 | -86.8% | 2,785 | -87.6% | 0.00% | -100.0% |
| Q3 2013 | $844,000 | +49.4% | 22,489 | +6.9% | 0.00% | 0.0% |
| Q2 2013 | $565,000 | – | 21,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |